|
Sapisochin G, Rodríguez de Lope C, Gastaca M, Ortiz de Urbina J, Suarez MA, Santoyo J, Castroagudín JF, Varo E, López-Andujar R, Palacios F, Sanchez Antolín G, Perez B, Guiberteau A, Blanco G, González-Diéguez ML, Rodriguez M, Varona MA, Barrera MA, Fundora Y, Ferron JA, Ramos E, Fabregat J, Ciria R, Rufian S, Otero A, Vazquez MA, Pons JA, Parrilla P, Zozaya G, Herrero JI, Charco R, Bruix J. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant. 2014 Mar;14(3):660-7. doi: 10.1111/ajt.12591. PubMed PMID: 24410861.
AÑO: 2014; IF: 5.683
|
24410861
|
Berenguer M, Roche B, Aguilera V, Duclos-Vallée JC, Navarro L, Rubín A, Pons JA, de la Mata M, Prieto M, Samuel D. Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach. Liver Transpl. 2013 Jan;19(1):69-77. doi: 10.1002/lt.23555. PubMed PMID: 23008144.
AÑO: 2013; IF: 3.793
|
|
Garre-Sánchez MC, Álvarez-Higueras FJ, Muñoz-Tornero M, Ono-Ono A, Miras-López M, Pons-Miñano JA, Carballo-Álvarez LF. Colour-Doppler features of hepatic involvement in Rendu-Osler-Weber disease. Rev Esp Enferm Dig. 2013 Nov-Dec;105(10):622-3. PubMed PMID: 24641459.
AÑO: 2013; IF: 1.317
|
|
Gómez-Bravo MA, Salcedo M, Fondevila C, Suarez F, Castellote J, Rufian S, Pons JA, Alamo JM, Millán O, Brunet M. Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. J Clin Pharmacol. 2013 Nov;53(11):1146-54. doi: 10.1002/jcph.154. PubMed PMID: 23900887.
AÑO: 2013; IF: 2.472
|
|
López-Navas A, Ríos A, Martínez-Alarcón L, Febrero B, Pons JA, Miras M, Ramis G, Ramírez P, Parrilla P. Patients with terminal chronic liver pathology faced with this disease. Transplant Proc. 2013;45(10):3630-2. doi: 10.1016/j.transproceed.2013.11.005. PubMed PMID: 24314979.
AÑO: 2013; IF: 0.984
|